Ark INNOVATION UCITS ETF (ETR:ARXK)
Germany · Delayed Price · Currency is EUR 7.66
+0.06 (0.75%)
At close: Jun 19, 2026
30.10% (1Y)
| Assets | 260.97M |
| Expense Ratio | 0.78% |
| PE Ratio | 53.17 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | +30.10% |
| Volume | 25,601 |
| Open | 7.69 |
| Previous Close | 7.60 |
| Day's Range | 7.66 - 7.71 |
| 52-Week Low | 5.74 |
| 52-Week High | 8.21 |
| Beta | 0.42 |
| Holdings | 45 |
| Inception Date | Apr 12, 2024 |
About ARXK
ARXK.DE was created on 2024-04-12 by ARK. The fund's investment portfolio concentrates primarily on theme equity. The ETF currently has 249.89m in AUM and 45 holdings. This product is actively managed and invests primarily in global equity securities of companies involved in disruptive innovation, defined as the introduction of a technologically enabled new product or service that potentially changes the way the world works.
Asset Class Equity
Category Theme
Stock Exchange Deutsche Börse Xetra
Ticker Symbol ARXK
Provider ARK
Performance
ARXK had a total return of 30.10% in the past year, including dividends. Since the fund's inception, the average annual return has been 31.88%.
Top 10 Holdings
49.37% of assets| Name | Symbol | Weight |
|---|---|---|
| Tesla, Inc. | TSLA | 8.27% |
| Robinhood Markets, Inc. | HOOD | 6.71% |
| Advanced Micro Devices, Inc. | AMD | 5.47% |
| CRISPR Therapeutics AG | CRSP | 5.25% |
| Space Exploration Technologies Corp. | SPCX | 4.71% |
| Tempus AI, Inc. | TEM | 4.16% |
| Beam Therapeutics Inc. | BEAM | 3.94% |
| Roku, Inc. | ROKU | 3.73% |
| Coinbase Global, Inc. | COIN | 3.57% |
| Twist Bioscience Corporation | TWST | 3.56% |